FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site): FDA inspection ending May 14, 2018
FDA inspection 1053612 · Voluntary Action Indicated (VAI) · Lianyungang
Key facts
| Inspection ID | 1053612 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| FEI number | 3007373503 |
| Address | Dev. Zone, Economic & Technological; 38 Huanghe Avenue |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | May 14, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data